V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270013175 | 270014111 | 1.69 | 101.2 | Curative (C) | 2016-10-05 | 2016-11-27 | Trial Unspecified | 2 | null | 270014097 | TRIAL |
| 270013176 | 270014111 | 1.7 | 41.1 | Curative (C) | 2016-08-05 | 2016-09-09 | Cetuximab 7 day (>Cycle 2) | 02 | N | 270014097 | CETUXIMAB |
| 270013177 | 270014111 | 1.67 | 38.4 | Palliative (P) | 2013-12-28 | 2014-02-06 | Cetuximab 14 day | N | null | 270014097 | CETUXIMAB |
| 270013178 | 270008708 | 1.51 | 42.4 | Curative (C) | 2017-03-13 | 2017-03-21 | Trial Unspecified | N | Y | 270014136 | TRIAL |
| 270013179 | 270008708 | 1.69 | 56.2 | Palliative (P) | 2015-12-21 | 2017-04-08 | CETUXIMAB | null | null | 270014136 | CETUXIMAB |
| 270013180 | 270008709 | null | 58.2 | Curative (C) | 2016-06-03 | 2016-06-08 | Escalated BEACOPP | N | null | 270014148 | BEACOPP |
| 270013181 | 270008710 | 1.69 | 70.1 | Curative (C) | 2015-08-01 | 2015-08-01 | Escalated BEACOPP | N | N | 270014150 | BEACOPP |
| 270013182 | 270014113 | 1.55 | 78.8 | Adjuvant (A) | 2015-09-29 | 2015-09-30 | COPP + Dacarbazine | 02 | N | 270014156 | COPP + DACARBAZINE |
| 270013183 | 270008711 | 0 | null | Curative (C) | 2013-10-03 | 2013-12-03 | HD EuroNet-PHL-C1 COPDAC | 01 | N | 270014163 | TRIAL |
| 270013184 | 270008715 | 1.85 | 94.8 | Adjuvant (A) | 2015-03-31 | 2015-03-31 | HD EuroNet-PHL-C1 COPDAC | N | N | 270014165 | TRIAL |
| 270013185 | 270014115 | null | 63.1 | Neo-adjuvant (N) | 2014-05-31 | 2014-08-08 | COPP + Dacarbazine | N | N | 270014168 | COPP + DACARBAZINE |
| 270013186 | 270008717 | 0 | 61.9 | Neo-adjuvant (N) | 2013-02-10 | 2013-02-11 | COPP + Dacarbazine | 02 | N | 270014176 | COPP + DACARBAZINE |
| 270013187 | 270008718 | 1.81 | 67.9 | Curative (C) | 2017-12-18 | 2017-12-18 | COPP + Dacarbazine | N | null | 270014178 | COPP + DACARBAZINE |
| 270013188 | 270008719 | 1.88 | 60 | Curative (C) | 2014-09-30 | 2014-10-16 | COPP + Dacarbazine | 2 | null | 270014178 | COPP + DACARBAZINE |
| 270013189 | 270016735 | 1.59 | 48 | Curative (C) | 2016-03-11 | 2016-03-16 | Escalated BEACOPP | N | N | 270014199 | BEACOPP |
| 270013190 | 270008725 | 0 | 32.4 | Palliative (P) | 2017-04-22 | 2017-04-24 | COPP + Dacarbazine | N | null | 270014201 | COPP + DACARBAZINE |
| 270013191 | 270008726 | 1.43 | 73.6 | Curative (C) | 2015-12-13 | 2015-12-27 | COPP + Dacarbazine | N | N | 270014204 | COPP + DACARBAZINE |
| 270013192 | 270008727 | 1.51 | null | Curative (C) | 2014-06-22 | 2014-06-23 | COPP + Dacarbazine | 2 | Y | 270014217 | COPP + DACARBAZINE |
| 270013193 | 270008728 | 0 | 72 | null | 2013-09-25 | 2013-11-25 | COPP + Dacarbazine | 2 | null | 270014220 | COPP + DACARBAZINE |
| 270013194 | 270016738 | null | 73.2 | Curative (C) | 2013-11-22 | 2013-12-18 | HD EuroNet-PHL-C1 COPDAC | N | Y | 270014221 | TRIAL |
| 270013195 | 270008732 | 0 | 94.8 | Curative (C) | 2016-06-15 | 2016-08-01 | Trial Unspecified | Y | N | 270014229 | TRIAL |
| 270013196 | 270008733 | 1.75 | 101 | Curative (C) | 2013-07-08 | 2013-07-11 | HD EuroNet-PHL-C1 COPDAC | N | N | 270014230 | TRIAL |
| 270013197 | 270008733 | 1.8 | 73.4 | null | 2017-02-03 | 2017-02-03 | BEACOPP-14 | N | N | 270014230 | BEACOPP |
| 270013198 | 270008734 | 1.82 | 63.1 | Palliative (P) | 2015-07-15 | 2015-07-20 | Cetuximab 14 day | N | N | 270014242 | CETUXIMAB |
| 270013199 | 270016739 | 1.66 | 79 | Curative (C) | null | 2015-08-03 | Cetuximab 14 day | 02 | N | 270014243 | CETUXIMAB |
| 270013200 | 270008736 | null | 98.2 | Adjuvant (A) | 2016-07-26 | 2016-07-27 | COPP + Dacarbazine | N | N | 270014246 | COPP + DACARBAZINE |
| 270013201 | 270008737 | 1.51 | 59.7 | Curative (C) | 2017-06-19 | 2017-06-28 | Cetuximab 14 day | N | N | 270014247 | CETUXIMAB |
| 270013202 | 270008738 | 1.69 | 85 | Curative (C) | 2014-03-12 | 2014-03-12 | HD EuroNet-PHL-C1 COPDAC | 01 | null | 270014255 | TRIAL |
| 270013203 | 270008739 | 0 | 94.7 | Neo-adjuvant (N) | 2013-04-30 | 2013-04-30 | COPP + Dacarbazine | N | N | 270014256 | COPP + DACARBAZINE |
| 270013204 | 270008739 | 0 | 131.9 | Curative (C) | 2015-05-14 | 2015-05-14 | Trial Unspecified | 01 | N | 270014256 | TRIAL |
| 270013205 | 270008739 | 1.85 | 31.2 | Disease modification (D) | 2016-08-23 | 2017-08-26 | Trial Unspecified | N | N | 270014256 | TRIAL |
| 270013206 | 270008741 | 1.78 | 38.4 | null | 2015-01-23 | 2015-01-29 | BEACOPP | 02 | N | 270014267 | BEACOPP |
| 270013207 | 270008742 | 0 | 115 | Curative (C) | null | 2018-02-10 | COPP + Dacarbazine | 02 | N | 270014274 | COPP + DACARBAZINE |
| 270013208 | 270008744 | null | 59.1 | Curative (C) | 2015-07-22 | 2015-08-26 | CETUXIMAB | N | N | 270014274 | CETUXIMAB |
| 270013209 | 270008745 | 1.58 | 85 | Neo-adjuvant (N) | null | 2018-06-18 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270014282 | TRIAL |
| 270013210 | 270014130 | null | 42.8 | Curative (C) | 2013-09-09 | 2013-09-15 | Cetuximab 14 day | N | N | 270014283 | CETUXIMAB |
| 270013211 | 270008746 | 1.83 | 42.2 | Curative (C) | 2016-06-17 | 2017-12-05 | CETUXIMAB | N | N | 270014286 | CETUXIMAB |
| 270013212 | 270014131 | 1.62 | 79 | Curative (C) | null | 2014-09-13 | CETUXIMAB | N | N | 270014291 | CETUXIMAB |
| 270013213 | 270016743 | null | 73.45 | Curative (C) | null | 2013-12-02 | Escalated BEACOPP | N | null | 270014291 | BEACOPP |
| 270013214 | 270016743 | 0 | 52.1 | Adjuvant (A) | 2013-10-23 | 2013-10-27 | COPP + Dacarbazine | N | N | 270014291 | COPP + DACARBAZINE |
| 270013215 | 270016743 | 1.75 | 34.5 | Palliative (P) | 2016-11-19 | 2016-11-20 | Cetuximab 14 day | 2 | N | 270014291 | CETUXIMAB |
| 270013216 | 270008749 | 1.33 | 106.9 | Curative (C) | 2017-06-03 | 2017-06-09 | Trial Unspecified | N | null | 270014311 | TRIAL |
| 270013217 | 270014132 | 0 | 58.3 | Curative (C) | 2015-08-20 | 2015-10-26 | HD EuroNet-PHL-C1 COPDAC | N | N | 270014314 | TRIAL |
| 270013218 | 270008750 | 1.86 | 94.2 | Curative (C) | 2014-08-30 | 2014-08-30 | Escalated BEACOPP | 01 | null | 270014320 | BEACOPP |
| 270013219 | 270008750 | 0 | 60.8 | Curative (C) | 2015-01-11 | 2015-01-25 | COPP + Dacarbazine | N | N | 270014320 | COPP + DACARBAZINE |
| 270013220 | 270016744 | 0 | null | Palliative (P) | 2014-07-06 | 2014-10-19 | COPP + Dacarbazine | N | N | 270014350 | COPP + DACARBAZINE |
| 270013221 | 270008753 | 1.75 | 60 | Curative (C) | 2015-04-17 | 2015-05-06 | COPP + Dacarbazine | 02 | N | 270014354 | COPP + DACARBAZINE |
| 270013222 | 270008755 | 1.85 | 53.8 | Curative (C) | 2013-12-17 | 2013-12-27 | HD EuroNet-PHL-C1 COPDAC | 01 | N | 270014354 | TRIAL |
| 270013223 | 270019127 | null | 27.4 | Curative (C) | 2013-04-15 | 2013-04-16 | HD EuroNet-PHL-C1 COPDAC | N | null | 270014372 | TRIAL |
| 270013224 | 270008757 | null | 62.7 | Palliative (P) | 2013-03-14 | 2013-03-14 | CETUXIMAB | 2 | N | 270014372 | CETUXIMAB |